Antitumor immunity and advances in cancer immunotherapy

Breast Cancer. 2017 Jan;24(1):1-2. doi: 10.1007/s12282-016-0744-x.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Breast Neoplasms / immunology*
  • Breast Neoplasms / therapy*
  • CTLA-4 Antigen / immunology
  • Cancer Vaccines / immunology
  • Female
  • Humans
  • Immunotherapy / methods*
  • Lymphocytes, Tumor-Infiltrating / immunology
  • Lymphocytes, Tumor-Infiltrating / pathology
  • Programmed Cell Death 1 Receptor / immunology

Substances

  • CTLA-4 Antigen
  • Cancer Vaccines
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor